Subscribe To
Cellectis Announces Closing of Global Offering and Exercise of Underwriters’ Option to Purchase Additional Shares
NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) — Cellectis S.A. (“Cellectis” or the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today: the initial closing on February 7, 2023 of the previously announced underwritten global offering by way of […] The post Cellectis Announces Closing of Global Offering and Exercise of Underwriters’ Option to Purchase Additio...
Read More
Posted: Feb 8 2023, 00:01
Author Name: forextv
Views: 111718